相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas
I. S. Haldorsen et al.
BRITISH JOURNAL OF CANCER (2014)
Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer
David R. Parkinson et al.
CLINICAL CANCER RESEARCH (2014)
Clinical value of DNA content assessment in endometrial cancer
Karen Klepsland Mauland et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2014)
Serum HE4 as a prognostic marker in endometrial cancer - A population based study
Donal. J. Brennan et al.
GYNECOLOGIC ONCOLOGY (2014)
The Search Continues Looking for Predictive Biomarkers for Response to Mammalian Target of Rapamycin Inhibition in Endometrial Cancer
Larissa A. Meyer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Cancer Systems Biology: a peek into the future of patient care?
Henrica M. J. Werner et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
Henrica M. J. Werner et al.
PLOS ONE (2014)
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
Sofie L. Antonsen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2013)
Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer
Yoshimichi Tanaka et al.
CANCER BIOLOGY & THERAPY (2013)
Lack of Estrogen Receptor-α Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Elisabeth Wik et al.
CLINICAL CANCER RESEARCH (2013)
Companion Biomarkers: Paving the Pathway to Personalized Treatment for Cancer
Michael J. Duffy et al.
CLINICAL CHEMISTRY (2013)
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
Jone Trovik et al.
EUROPEAN JOURNAL OF CANCER (2013)
Sentinel lymph node mapping with pathologic ultrastaging: A valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion
Christine H. Kim et al.
GYNECOLOGIC ONCOLOGY (2013)
MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - A multicenter prospective comparative study
Sofie Leisby Antonsen et al.
GYNECOLOGIC ONCOLOGY (2013)
Molecular pathology of endometrial carcinoma
Xavier Matias-Guiu et al.
HISTOPATHOLOGY (2013)
Designing Transformative Clinical Trials in the Cancer Genome Era
Stefan Sleijfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
Alain G. Zeimet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
Henrica M. J. Werner et al.
MODERN PATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Implementing personalized cancer genomics in clinical trials
Richard Simon et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review
H. M. P. Pelikan et al.
CANCER IMAGING (2013)
Clinicopathologic Analysis of Matched Primary and Recurrent Endometrial Carcinoma
Robert A. Soslow et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
C. Krakstad et al.
BRITISH JOURNAL OF CANCER (2012)
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
E. Birkeland et al.
BRITISH JOURNAL OF CANCER (2012)
Intratumor Heterogeneity: Evolution through Space and Time
Charles Swanton
CANCER RESEARCH (2012)
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2012)
Development and Use of Integral Assays in Clinical Trials
Richard L. Schilsky et al.
CLINICAL CANCER RESEARCH (2012)
High EGFR Gene Copy Number and Skin Rash as Predictive Markers for EGFR Tyrosine Kinase Inhibitors in Patients with Advanced Squamous Cell Lung Carcinoma
Youngjoo Lee et al.
CLINICAL CANCER RESEARCH (2012)
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
Laura Zanotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques
I. S. Haldorsen et al.
CLINICAL RADIOLOGY (2012)
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation
Remi A. Nout et al.
GYNECOLOGIC ONCOLOGY (2012)
Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas
Ingfrid S. Haldorsen et al.
GYNECOLOGIC ONCOLOGY (2012)
HE4 is an independent prognostic marker in endometrial cancer patients
Irene Mutz-Dehbalaie et al.
GYNECOLOGIC ONCOLOGY (2012)
Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective
Jone Trovik et al.
GYNECOLOGIC ONCOLOGY (2012)
The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
James Nicklin et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
Filip Janku et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
Eitan Amir et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Contemporary management of endometrial cancer
Jason D. Wright et al.
LANCET (2012)
Markers for individualised therapy in endometrial carcinoma
Helga B. Salvesen et al.
LANCET ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
Sara A. Byron et al.
PLOS ONE (2012)
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
Manohar Pradhan et al.
VIRCHOWS ARCHIV (2012)
Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment
Oluwole Fadare et al.
JOURNAL OF CANCER (2012)
Prognostic Value of E-Cadherin Expression and CDH1 Promoter Methylation in Patients With Endometrial Carcinoma
Tie-Zhong Yi et al.
CANCER INVESTIGATION (2011)
PIK3R1 (p85α) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
Mary E. Urick et al.
CANCER RESEARCH (2011)
Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer
Jone Trovik et al.
CLINICAL CANCER RESEARCH (2011)
Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer
Anne Cathrine Staff et al.
CLINICAL CANCER RESEARCH (2011)
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature
Cagatay Arslan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer
Erica Ambeba et al.
FUTURE ONCOLOGY (2011)
Three-dimensional ultrasound for assessing women with gynecological cancer: A systematic review
Juan Luis Alcazar et al.
GYNECOLOGIC ONCOLOGY (2011)
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
John P. A. Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
Kimberly C. Wiegand et al.
JOURNAL OF PATHOLOGY (2011)
Trends in Endometrial Cancer Incidence Rates in the United States, 1999-2006
Linh M. Duong et al.
JOURNAL OF WOMENS HEALTH (2011)
Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma
Anita Steinbakk et al.
MODERN PATHOLOGY (2011)
Emerging therapeutic targets in endometrial cancer
Konstantin J. Dedes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury?
Mustafa Khasraw et al.
CURRENT ONCOLOGY REPORTS (2011)
High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Lydia W. T. Cheung et al.
CANCER DISCOVERY (2011)
Para-aortic Lymphadenectomy in the Management of Preoperative Grade 1 Endometrial Cancer Confined to the Uterine Corpus
Jong-Hyuck Yoon et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
Marcos Ballester et al.
BMC CANCER (2010)
Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
Janet E. Dancey et al.
CLINICAL CANCER RESEARCH (2010)
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2010)
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer
Jone Trovik et al.
HISTOPATHOLOGY (2010)
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
Karuna Garg et al.
MODERN PATHOLOGY (2010)
Translating cancer research into targeted therapeutics
J. S. de Bono et al.
NATURE (2010)
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
Alastair M. Thompson et al.
BREAST CANCER RESEARCH (2010)
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
C. Simmons et al.
ANNALS OF ONCOLOGY (2009)
Systemic therapy for recurrent endometrial cancer: a review of North American trials
Thanh H. Dellinger et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
Vincent Jongen et al.
GYNECOLOGIC ONCOLOGY (2009)
Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
Nadeem R. Abu-Rustum et al.
GYNECOLOGIC ONCOLOGY (2009)
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
Sergio Pecorelli
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis
Lluis Catasus et al.
MODERN PATHOLOGY (2009)
Efficacy of systematic pelvic endometrial cancer (MRC ASTEC trial): a randomised study
H. Kitchener et al.
LANCET (2009)
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H. B. Salvesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
Ingeborg B. Engelsen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation
Yutaka Suehiro et al.
CLINICAL CANCER RESEARCH (2008)
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
Pierluigi Benedetti Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Drug-sensitive FGFR2 mutations in endometrial carcinoma
Amit Dutt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data
Abdulmohsen Alkushi et al.
MODERN PATHOLOGY (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma - DNA aneuploidy identifies high-risk cases among the so-called low-risky patients with well and moderately differentiated tumors
Tommaso Susini et al.
CANCER (2007)
Economics of new oncology drug development
Joseph A. DiMasi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hormone therapy in advanced and recurrent endometrial cancer: a systematic review
S. B. Decruze et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center
Nadeem R. Abu-Rustum et al.
GYNECOLOGIC ONCOLOGY (2006)
Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas
Ingeborg B. Engelsen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
HER-2 is an independent prognostic factor in endometrial cancer: Association with outcome in a large cohort of surgically staged patients
C Morrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Endometrial cancer: can nodal status be predicted with curettage?
A Mariani et al.
GYNECOLOGIC ONCOLOGY (2005)
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer
IM Stefansson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
